Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain

Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain

Background: The efficacy and safety of secukinumab in patients with plaque psoriasis (PsO) have been demonstrated in randomized clinical trials (RCTs). However, data regarding its efficacy and safety in real-life settings are scarce. Objectives: To evaluate the efficacy and safety of secukinumab in...

Full description

Bibliographic Details
Main Authors: Jaime Notario, Gustavo Deza, Eva Vilarrasa, Francesc Valentí, Carlos Muñoz, Jordi Mollet, Vicenç Rocamora, Jose-Manuel Carrascosa, Elena del Alcázar, Mercè Alsina, David Vidal, Lluís Puig, Anna López-Ferrer, José Riera, Fernando Gallardo, Marta Ferran
Format: Article
Language:English
Published: Taylor & Francis Group 2019-07-01
Series:Journal of Dermatological Treatment
Subjects:
psoriasis
biologics
secukinumab
safety
effectiveness
daily clinical practice
Online Access:http://dx.doi.org/10.1080/09546634.2018.1528000

Internet

http://dx.doi.org/10.1080/09546634.2018.1528000

Similar Items